Imagistx has developed an ultra high resolution ultrasound system that provides significant improvements in detecting prostate cancer (as per initial Clinical Study by Johns Hopkins). The system will be sold to private practice urologists, hospitals and imaging centers. Imagistx is now running a multi-site 960-patient clinical study that will statistically prove the superiority of the system against the standard of care and drive up adoption.